Tower Research Capital (TRC)’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-65
| Closed | – | – | 6192 |
|
|
2021
Q4 | $0 | Sell |
65
-121
| -65% | – | ﹤0.01% | 6235 |
|
|
2021
Q3 | $2K | Buy |
+186
| New | +$2K | ﹤0.01% | 5252 |
|
|
2021
Q2 | – | Sell |
-2,489
| Closed | -$28K | – | 5553 |
|
|
2021
Q1 | $28K | Buy |
+2,489
| New | +$28K | ﹤0.01% | 3605 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | – | – | 3951 |
|
|
2016
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3818 |
|
|
2016
Q2 | $0 | Sell |
1
-5
| -83% | – | ﹤0.01% | 4544 |
|
|
2016
Q1 | $1K | Sell |
6
-33
| -85% | -$5.5K | ﹤0.01% | 3672 |
|
|
2015
Q4 | $6K | Buy |
+39
| New | +$6K | ﹤0.01% | 2752 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4193 |
|
|
2015
Q2 | – | Sell |
-14
| Closed | -$3K | – | 4531 |
|
|
2015
Q1 | $3K | Sell |
14
-8
| -36% | -$1.71K | ﹤0.01% | 3551 |
|
|
2014
Q4 | $6K | Buy |
22
+14
| +175% | +$3.82K | ﹤0.01% | 2579 |
|
|
2014
Q3 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 3795 |
|